88 Energy (EEENF) Stock Soars 35% in a Month: More to Come?
After having gone through a fair degree of volatility, the oil and gas company 88 Energy (OTCMKTS:EEENF) saw its stock make a strong move over the course of the past month.
The stock has come into the radars of many traders in a big way and over the course of the past month, it managed to clock gains of as much as 35%. The fresh momentum in the stock is something that investors need to look into closely before they make any decision one way or another. There are two main factors that drove the rally in the stock. Last month 88 Energy had announced that it had sold off its oil and gas credits from its Alaskan interests for a total of $18.7.
While that was a nice chunk of change for 88 Energy, the company decided to pay off the entirety of its debts amounting to $16.1 million. The company added at the time that the rest of the money from the sale was going to be used for working capital needs and also for strengthening its balance sheet.
The company’s operations are very small when compared to some of the other oil and gas companies, which is why it was such a major development and led to such excitement among investors. The other important development was 88 Energy’s decision to issue as many as 204 million fully paid-up shares in the company at $0.026 a share. The proceeds for the same was used to pick up a 50% stake in Project Peregrine.
Enzolytics Inc (ENZC) Stock Gains Further Momentum: What’s Ahead?
If you are into micro-cap stocks then you might have noticed that Enzolytics Inc (OTCMKTS:ENZC) has emerged as one of the major movers this year so far and the rally in the stock continued over the course of the past week. During that period, the stock attracted plenty of investors and ended up clocking gains of as much as 22%.
Considering the magnitude of the gains made by the stock it might be a good idea for investors to take a look at a development earlier this week that might have brought about the latest rally. The company announced that it inked a letter of intent with Creative Biolabs which stipulates that the two companies are going to work on the commercialization and development of HTLV-1 monoclonal antibodies.
The two companies are going to accomplish that by combining their technologies. It was a significant development for Enzolytics considering the fact that at this point in time there are no antiviral medicines or vaccines that can tackle HTLV-1. As a result, the fact that the company has now decided to collaborate on a project on the same thing has come as a source of considerable excitement for investors.
In this project, the Artificial Intelligence method that belongs to Enzolytics is going to be deployed for the purpose of identifying the conserving immutable target sites that can be found on the HTLV-1 virus. Creative will be responsible for testing the efficacy and neutralising capabilities of the monoclonal antibodies, among other duties.
Moderna Inc (NASDAQ:MRNA) Stock Pulls Back To $300 After The Monster Rally
Over the course of the past months, the Moderna Inc (NASDAQ:MRNA) stock has been on the radar of most investors due to the company’s stellar work with regard to the COVID-19 vaccine. However, the stock is in focus among investors yet again for a different reason.
From today, the Modern stock is going to be included in the prestigious S&P 500 index and will replace Alexion Pharmaceuticals Inc. In recent months, the Modern stock has recorded considerable gains since its vaccine became one of the most widely used vaccines during the coronavirus pandemic. That being said, there are experts who believe that the stock is currently overpriced. Senior Research Analyst and Managing Director of the firm Jeffries, Michael Yee spoke about the Modern stock price at length during the course of a discussion with Yahoo Finance.
Yee stated that due to the success of its vaccine, the company’s stock has taken on ‘taken on a life of its own which is not entirely rooted in reality. He went on to state that at this point in time, the stock price seems to have priced in a wide range of assumptions over the course of the next decade. He added that those assumptions are yet to bear fruit and suggested that investors seem to believe that Modern is now the ‘Tesla of biotech’. Despite that, it cannot be denied that addition to the S&P 500 today is a major development for the company and it remains to be seen if it leads to a further spike in the Moderna stock price.
HIVE Blockchain Technologies (HVBT) (HIVE) Stock Attempts To Bounce Back: A Buy Now?
Investors are now increasingly interested in stocks of companies that are involved in the blockchain and cryptocurrency sectors. One of the companies from the sector to have garnered considerable attention in recent times is HIVE Blockchain Technologies Ltd (NASDAQ:HVBT) (CVE:HIVE).
The stock was in action yesterday and ended up clocking gains of as much as 11% as investors piled on to it. That being said, it is also necessary to remember that there was no news about the company yesterday that could have led to such gains. However, earlier this month the company made a key announcement and informed that it joined up with the NVIDIA Partner Network Cloud Service Provider program. It was a major development for the company and might have been one of the reasons behind the positivity around the stock.
However, in addition to joining up with the program, HIVE Blockchain also announced that it signed purchase agreements for NVIDIA’s GPUs in a contract that is worth in excess of $66 million.
This move is a major step for the company since it is expected to help the company to move into the lucrative Enterprise Cloud services space that is dedicated to High-Performance Computing niche. In addition to that, entry into the program is also going to help HIVE Blockchain in accessing the customers and partners which belong to NVIDIA. In other words, HIVE Blockchain will be part of a strong ecosystem and will also be able to take advantage of the considerable industry knowledge of NVIDIA.
Netlist Inc (NLST) stock Rockets 1100% YTD: Will it Hit $20?
Investors are often known to be more interested in stocks that might have recorded considerable gains over a reasonable period of time and by that token, it might be a good idea for investors to possibly take a look at the Netlist Inc (OTCMKTS:NLST) stock.
The stock has been one of the more notable performers this year so far and over the course of the past six months alone, it has managed to record gains of as much as 1100%. As a matter of fact, the stock was actually on the move on Monday as well and delivered gains of 7%. There was no news about the company on Monday but it might be a good time to mention that last week the company had announced the signing of Securities Purchase Agreement with the firm Lincoln Park Capital Inc.
As per the provisions of the agreement between the two parties, Lincoln Park is going to acquire shares in Netlist over a period of the next 36 months for a total value of $17400000. The 36 month period stipulated in the agreement already begun on July 12, 2021, and in addition to that, Netlist also signed a registration rights agreement with Lincoln Park. The latest development in relation to Netlist seems to have come as a source of excitement among investors and it is going to be interesting to see if the stock can continue to hold on to its momentum over the course of the coming days.
Relief Therapeutics Holding AG (RLFTF) Stock Makes a Strong Comeback: What Next?
In recent times many biopharmaceutical companies have come into focus among investors in a big way and one of those is Relief Therapeutics Holding AG (OTCMKTS:RLFTF).
The stock has come into sharp focus already after a key announcement from the company this morning and soared by as much as 29% at the time of writing. This morning the company announced that the parent’s company of NRx Pharmaceuticals Inc, its collaboration partner, sent out a press release on Monday with regards to the considerable effect that aviptadil had in preventing the rise in cytokines in critically ill COVID 19 patients. It is a significant development for Relief Therapeutics and hence, the strong rally in the stock is perhaps understandable.
As per the press release from NRx Pharmaceuticals’ parent company, the data with regards to cytokine was collected from the Phase 2b/3 trial of aviptadil. During the course of this trial, the response in patients who had been administered with aviptadil were compared to those who had been treated with a placebo.
In addition to that, NRx Pharmaceuticals also announced that these findings were handed over to the United States Food and Drug Administration. The data was handed over as part of a supplement to its existing Emergency Use Authorization with the agency. Additionally, NRx Pharmaceuticals also noted that it has been cooperating with regard to any requests for additional information from the FDA. All this certainly bodes well for Relief Therapeutics, which has to collaborate with NRx on this project and it remains to be seen if the stock continues to add to its gains through the rest of the week.
PHI Group Inc (OTCMKTS:PHIL) Stock Consolidates After The Big Move
Every day thousands upon thousands of investors hunt the market for the latest big movers in the micro-cap space and it is easy to see why. These stocks may be volatile but are known to generate considerable gains within a short period of time.
After having recorded handsome gains earlier, the PHI Group Inc (OTCMKTS:PHIL) stock has been trading within a range in recent days. It is often seen that stocks that trade within a range can often move either way eventually and hence, it might be a good idea to take a look into it. Last week, the PHI Group stock had made an explosive move up the charts and emerged as one of the most popular micro-cap stocks in the market.
As a matter of fact, the stock attracted a large volume of new investors and there was heavy accumulation in the PHI Group stock. However, one of the most important things to point out in this regard is the fact that PHI Group commands a major international following among stock market speculators and that has been another major factor behind the dramatic rise in the stock price.
The rally in the stock actually started back in December 2020 as many new penny stock speculators got into it in a big way and pushed the price up progressively. Moreover, the speculation among investors who are active on many online platforms was also a factor in the rising popularity of the PHI Group stock in the past months.
Net Savings Link Inc (NSAV) Stock Makes a Bullish Move: How to Trade This Week?
Over the course of the past year or so, many companies which are involved in the cryptocurrency sector have come into considerable focus among investors and one such company is Net Savings Link Inc (OTCMKTS:NSAV).
The company is involved in the cryptocurrency, blockchain, and digital asset technology spaces and has emerged as one of the more popular cryptocurrency stocks among investors. Last week, the Net Savings stock was on fire and managed to record gains of as much as 120% as investors piled on to it in a big way following a key announcement on July 12. The company announced that its highly anticipated cryptocurrency exchange is going to be launched on August 9 this year. It was a major announcement and resulted in considerable excitement about the stock among investors.
The company went on to state that the exchange is going to be entirely owned by Net Savings Link and will also bear its brand name. Net Savings revealed that considerable progress has been made in the project and the company is going to reveal further details about the project every week.
As a matter of fact, the company has even placed a countdown timer on its official website so that shareholders and visitors to the website can get to know exactly how much time is left for the launch of the cryptocurrency exchange at any given point. The company’s management boasts of considerable experience in the crypto space and are regarded as pioneers in their own right. Hence, there is expected to be considerable excitement about its new exchange.